These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 23786277)
21. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Montuschi P; Santonico M; Mondino C; Pennazza G; Mantini G; Martinelli E; Capuano R; Ciabattoni G; Paolesse R; Di Natale C; Barnes PJ; D'Amico A Chest; 2010 Apr; 137(4):790-6. PubMed ID: 20081096 [TBL] [Abstract][Full Text] [Related]
22. The versatile use of exhaled volatile organic compounds in human health and disease. Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865 [TBL] [Abstract][Full Text] [Related]
23. The electronic nose in respiratory medicine. Montuschi P; Mores N; Trové A; Mondino C; Barnes PJ Respiration; 2013; 85(1):72-84. PubMed ID: 23018197 [TBL] [Abstract][Full Text] [Related]
24. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air. Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084 [TBL] [Abstract][Full Text] [Related]
25. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose. Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436 [TBL] [Abstract][Full Text] [Related]
26. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554 [TBL] [Abstract][Full Text] [Related]
27. Potential of the Electronic Nose for the Detection of Respiratory Diseases with and without Infection. Licht JC; Grasemann H Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321951 [TBL] [Abstract][Full Text] [Related]
29. Established methodological issues in electronic nose research: how far are we from using these instruments in clinical settings of breath analysis? Bikov A; Lázár Z; Horvath I J Breath Res; 2015 Jun; 9(3):034001. PubMed ID: 26056127 [TBL] [Abstract][Full Text] [Related]
30. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis. de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298 [TBL] [Abstract][Full Text] [Related]
32. Influence of circadian rhythm on exhaled breath profiling by electronic nose. Liotino V; Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O J Biol Regul Homeost Agents; 2018; 32(5):1261-1265. PubMed ID: 30334423 [TBL] [Abstract][Full Text] [Related]
33. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
34. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
35. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study. Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380 [TBL] [Abstract][Full Text] [Related]
36. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Robroeks CM; van Berkel JJ; Jöbsis Q; van Schooten FJ; Dallinga JW; Wouters EF; Dompeling E Eur Respir J; 2013 Jul; 42(1):98-106. PubMed ID: 23645402 [TBL] [Abstract][Full Text] [Related]
37. An electronic nose in the discrimination of patients with asthma and controls. Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592 [TBL] [Abstract][Full Text] [Related]
38. Non-invasive breath monitoring with eNose does not improve glucose diagnostics in critically ill patients in comparison to continuous glucose monitoring in blood. Leopold JH; Bos LDJ; Colombo C; Sterk PJ; Schultz MJ; Abu-Hanna A J Breath Res; 2017 Apr; 11(2):026002. PubMed ID: 28260695 [TBL] [Abstract][Full Text] [Related]
39. Electronic nose breathprints are independent of acute changes in airway caliber in asthma. Lazar Z; Fens N; van der Maten J; van der Schee MP; Wagener AH; de Nijs SB; Dijkers E; Sterk PJ Sensors (Basel); 2010; 10(10):9127-38. PubMed ID: 22163399 [TBL] [Abstract][Full Text] [Related]
40. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients. Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]